2018 American Transplant Congress » Poster Session B: VCA

6:00pm-7:00pm

AMD3100 (Plerixafor) as a Single-Dose Stem Cell Mobilizing Agent in Vascularized Composite Tissue Allograft (VCA) Transplantation in a Canine Model

B. Swearingen,^1,2 S. Graves,^2,3 R. Storb,^2,3 D. Mathes.^1,2

6:00pm-7:00pm

Absence of Rejection in a Facial Allograft Recipient with a Postive Flow Crossmatch 24 Months after Induction with Rabbit Anti-Thymocyte Globulin and Anti-CD20+ Monoclonal Antibody

B. Gelb,¹ J. Diaz-Siso,² N. Plana,² A. Jacoby,² W. Rifkin,² K. Khouri,² D. Ceradini,² E. Rodriguez.²

6:00pm-7:00pm

Autologous Adipose-Derived Stem Cells with In Vivo Immunomodulatory Properties Can Be Generated in Allograft Recipients under Immunosuppression

A. Sicard,¹ J. Rodriguez,² P. Petruzzo,³ J. Kanitakis,⁴ O. Damour,² L. Badet,⁵ A. Gazarian,⁶ F. Buron,¹ O. Thaunat,¹ K. Tarte,⁷ C. Mesnard,⁷ C. Auxenfans,² E. Morelon.¹

6:00pm-7:00pm

Burden of Infectious Complications after Upper Extremity Allotransplantation: A Matched Cohort Study

A. Conrad,^1,2,3 P. Petruzzo,^4,5 J. Kanitakis,⁶ A. Gazarian,⁷ L. Badet,^3,8 P. Vanhems,^3,9 O. Thaunat,^1,3,10 E. Morelon,^1,3,10 A. Sicard.^1,3

6:00pm-7:00pm

Demand for Uterine Transplantation in the United States: Initial Recruitment Results of a Trial of Uterine Transplantation in the Northeast U.S.

P. Porrett,¹ N. Latif,² E. Wang,² L. Sortor,³ S. Levin,⁴ A. Shaked,¹ K. Olthoff,¹ C. Coutifaris,² D. Driscoll,² K. O'Neill.²

6:00pm-7:00pm

Ex-Vivo Subnormothermic Oxygenated Machine Perfusion of Rodent Hindlimb: Feasibility Study to Elongate Preservation Time of Vascularized Composite Allograft

L. Burlage,^1,2 A. Lellouch,^3,4 S. Tessier,¹ C. Pendexter,¹ S. Cronin,¹ M. Schol,³ M. Randolph,³ R. Porte,² L. Lantieri,⁴ C. Cetrulo,³ K. Uygun.¹

6:00pm-7:00pm

Experience with Immunosuppressive Strategies in Vascularized Composite Allotransplantation of Face

R. Klasek,¹ B. Kollar,² S. Tasigiorgos,² B. Pomahac.²

6:00pm-7:00pm

Facial Allotransplantation: An Early Look at OPTN Data

J. Wainright,¹ L. Levin,² L. Cendales,³ C. Wholley,¹ W. Cherikh,¹ D. Klassen,¹ B. Pomahac.⁴

6:00pm-7:00pm

Functional Reconstruction of Urogenital Tissue Defects Using VCA: A Novel Microsurgical Penis Transplant Model and Clinical & Histological Rejection Classification

S. Fidder,^1,4 G. Furtmüller,¹ B. Simons,² B. Kern,¹ D. Lough,¹ B. Oh,¹ M. Chicco,¹ C. Brayton,³ W. Lee,¹ D. Cooney,¹ R. Redett,¹ G. Brandacher.¹

6:00pm-7:00pm

Maintenance Immunosuppression Trends in Hand and Facial VCA Transplantation

A. Manjunath,¹ M. Cammarata,¹ R. Kantar,¹ W. Rifkin,¹ A. Jacoby,¹ B. Gelb,² R. Diaz-Siso,¹ E. Rodriguez.¹

6:00pm-7:00pm

Mayo Clinic's First Face Transplant: 17 Months On

H. Amer, S. Jowsey-Gregoire, C. Rosen, R. Razonable, K. Reid, M. Gandhi, L. Ewoldt, B. Edwards, S. Mardini.

6:00pm-7:00pm

OPTN VCA Waiting List Trends

J. Wainright, C. Wholley, W. Cherikh, J. Musick, D. Klassen.

6:00pm-7:00pm

Predicting Outcomes of Rat Vascularized Composite Allotransplants through Quantitative Measurement of Chimerism with PCR-Amplified Short Tandem Repeat

H. Cheng,¹ X. Huang,² C-.F. Lin,¹ N. AL Deek,² L. Shih,² C-.H. Lin,^1,2 F-.C. Wei.^1,2,3

6:00pm-7:00pm

Psychosocial Factors Affecting Recipients of Vascular Composite Allotransplantation

S. Rasmussen, M. Henderson, C. Cooney, J. Shores, W. Lee, D. Segev, G. Brandacher.

6:00pm-7:00pm

Rapamycin Therapy Impairs Treg Expression of CXCR3 and Limits Treg-Dependent Survival of Vascularized Composite Allotransplants

H. Xu,¹ Z. Chen,² W. Hancock,^3,4 S. Levin,⁵ Y. Zhang.¹

6:00pm-7:00pm

The Chauvet Workgroup: From Inception to the Future

H. Amer,¹ S. Jowsey-Gregoire,¹ M. Kumnig,² E. Moreno,³ W. Dean,⁴ C. Brown,⁵ S. Jarvholm,⁶ K. Coffman,⁷ P. Petruzzo,⁸ E. Morelon.⁸

6:00pm-7:00pm

The Preclinical Application of the Tactile Discrimination Task in Rat Models

S-.H. Wu,^1,2 C-.J. Wen,^1,2 J-.J. Huang,^1,2,3 Y-.C. Pei,^1,2,3 C-.H. Lin,^1,2,4,5 H. Cheng,¹ Z-.L. Peng,^1,4,5 H-.I. Yang,⁶ F-.C. Wei.^1,2,5

6:00pm-7:00pm

Triptolide Reduces the Required Dose of Tacrolimus by Attenuating Inflammation, Enhancing Immunosuppression, and Increasing Donor Chimerism in a Heterotopic Hindlimb Transplantation Model

C. Gu, F. Liu, J. Yang.

6:00pm-7:00pm

Upper Limb Transplantation in the US: An Early Look at OPTN Data

J. Wainright,¹ L. Levin,² C. Wholley,¹ W. Cherikh,¹ D. Klassen,¹ L. Cendales.³

6:00pm-7:00pm

Upper Limb and Craniofacial VCA Donors in the US

J. Wainright, C. Wholley, W. Cherikh, J. Rosendale, D. Klassen.